Centessa Pharmaceuticals-adr Share Price

NASDAQ: CNTA

Small Cap

$21.12

-0.89

(-4.06%)

Live

as on September 17, 2025 at 12:36 am IST

$₹

Centessa Pharmaceuticals-adr Stock Performance

as on September 17, 2025 at 12:36 am IST

Day's Low
Day's High
$20.94
Day's Price Range
$22.22
$21.12
0.85%
Downside
5.21%
Upside
52 Week's Low
52 Week's High
$9.6
52-Week Price Range
$23.24
$21.12
54.55%
Downside
10.04%
Upside

Centessa Pharmaceuticals-adr share price movements today

Previous Close: $22.02
Open: $22.18
Volume: 827.7K
Day's Low - High: $20.94 - $22.22
52 Week Low - High: $9.6 - $23.24

Centessa Pharmaceuticals-adr Historical Returns

1 Month Return: + 20.83 %
3 Month Return: + 73.1 %
1 Year Return: + 32.5 %
3 Year Return: + 406.03 %
5 Year Return: 0 %

Centessa Pharmaceuticals-adr Stock Fundamentals & Key Indicators

Check Centessa Pharmaceuticals-adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9B

EPS (TTM)

-1.3738

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-206.1M

Revenue (TTM)

15.0M

Profit Margin

0.00%

Return On Equity TTM

33482700.00%

Centessa Pharmaceuticals-adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Centessa Pharmaceuticals-adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Centessa Pharmaceuticals-adr	BUY	$2.9B	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Centessa Pharmaceuticals-adr Stock including INR - Dollar returns

The Centessa Pharmaceuticals-adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Centessa Pharmaceuticals-adr investment value today

Current value as on today

₹1,33,179

Returns

₹33,179

(+33.18%)

Returns from Centessa Pharmaceuticals-adr Stock

₹28,311 (+28.31%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Centessa Pharmaceuticals-adr Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Centessa Pharmaceuticals-adr. Average target price of $32.42

Centessa Pharmaceuticals-adr Share Price Target

Get share price movements and forecasts by analysts on Centessa Pharmaceuticals-adr.

What analysts predicted

34.86%UPSIDE

Target Price

$32.42

Current Price

$21.12

Analyzed by

11 Analysts

Target

$32.42

Centessa Pharmaceuticals-adr target price $32.42, a slight upside of 34.86% compared to current price of $21.12. According to 11 analysts rating.

Centessa Pharmaceuticals-adr Stock's Interest Amongst Investors

Search interest for Centessa Pharmaceuticals-adr Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:133% versus previous 30 day period

Centessa Pharmaceuticals-adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	6	-	-	-	0	15	-
Gross Profit	0	0	0	6	0	0	0	0	15	0
Operating Income	-48	-47	-40	-35	-36	-43	-46	-74	-30	-54
EBITDA	-47	-46	-38	-32	-34	-40	-39	-106	-21	-46
Interest Expense	2	2	2	2	2	2	2	2	2	2
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-50	-48	-41	-36	-37	-43	-41	-110	-24	-49
Income Tax Expense	0	-24	-2	1	0	0	0	1	1	0
Net Income	-50	-24	-38	-37	-38	-43	-42	-111	-26	-50
Net Profit Margin	0.00%	0.00%	0.00%	-537.49%	0.00%	0.00%	0.00%	-11691.13%	-174.23%	0.00%

Centessa Pharmaceuticals-adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	6	-
Gross Profit	-	-	0	6	0
Operating Income	-5	-10	-212	-171	-201
EBITDA	-4	-10	-207	-166	-221
Interest Expense	0	0	7	9	10
Depreciation	0	-	0	0	0
Income Before Tax	-5	-10	-216	-176	-233
Income Tax Expense	0	0	0	-25	2
Net Income	-5	-10	-216	-151	-235
Net Profit Margin	0.00%	0.00%	0.00%	-2204.65%	0.00%

Centessa Pharmaceuticals-adr Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-24	-38	-37	-38	-38	-42	-111	-26	-50
Operating Cash Flow	-44	-37	-31	-37	-37	-21	-42	-57	-22
Investing Cash Flow	-71	48	-18	16	-	44	25	-222	-39
Financing Cash Flow	0	14	6	10	10	245	2	3	1
Change in Cash	-114	26	-43	-9	-9	267	-11	-278	-60

Centessa Pharmaceuticals-adr Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-10	-381	-216	-151	-235
Operating Cash Flow	-10	-136	-200	-160	-142
Investing Cash Flow	63	63	0	-127	31
Financing Cash Flow	1	660	0	21	364
Change in Cash	-9	590	-201	-265	255

Global Institutional Holdings in Centessa Pharmaceuticals-adr

Funds	Holdings
Medicxi Ventures Management (Jersey) Ltd	14.94%
Index Venture Life Associates VI Ltd	7.46%
General Atlantic Llc	7.25%
Adage Capital Partners Gp LLC	5.2%
HHG PLC	4.43%

See all

Insights on Centessa Pharmaceuticals-adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, CNTA stock has moved up by 22.0%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CNTA has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 36.8%

About Centessa Pharmaceuticals-adr

centessa pharmaceuticals plc is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. the company applies an asset-centric r&d model at scale to advance a portfolio of highly validated programs led by industry leading teams. each program is developed by a centessa subsidiary and supported by a centralized infrastructure and the centessa management team. the company is headquartered in cambridge, mass.

Organisation	Centessa Pharmaceuticals-adr
Headquarters	1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
Industry	Healthcare
CEO	Dr. Saurabh Saha M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Centessa Pharmaceuticals-adr

Name	Title
Dr. Mario Alberto Accardi Ph.D.	President of the Orexin Program
Dr. Saurabh Saha M.D., Ph.D.	CEO & Director
Mr. John J. Crowley CPA	CFO & Principal Financial Officer
Mr. Iqbal J. Hussain L.L.B.	General Counsel, Chief Compliance Officer & Corporate Secretary
Ms. Tia L. Bush	Chief Technology & Quality Officer
Ms. Karen M. Anderson	Chief People Officer
Dr. Gregory M. Weinhoff M.B.A., M.D.	Chief Business Officer
Mr. Raphael Deferiere CPA	Chief Accounting Officer & Principal Accounting Officer
Ms. Kristen K. Sheppard Esq., J.D.	Senior Vice President of Investor Relations & Corporate Communications
Ms. Charlene Stoudt	Senior Vice President of Clinical Development Operations

FAQs

What is Centessa Pharmaceuticals-adr share price today?

Centessa Pharmaceuticals-adr share price today is $21.12 as on September 17, 2025 at 12:36 am IST. Centessa Pharmaceuticals-adr share today touched a day high of $22.22 and a low of $20.94.

What is the 52 week high and 52 week low for Centessa Pharmaceuticals-adr share?

Centessa Pharmaceuticals-adr share touched a 52 week high of $23.24 on September 11, 2025 and a 52 week low of $9.6 on April 9, 2025. Centessa Pharmaceuticals-adr stock price today i.e. September 17, 2025 at 12:36 am IST is trending at $21.12,which is 9.12% down from its 52 week high and 120.00% up from its 52 week low.

What is Centessa Pharmaceuticals-adr's market capitalisation today?

Centessa Pharmaceuticals-adr market capitalisation is $0.00T as on September 17, 2025 at 12:36 am IST.

How to invest in Centessa Pharmaceuticals-adr Stock (CNTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Centessa Pharmaceuticals-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Centessa Pharmaceuticals-adr Shares that will get you 0.0710 shares as per Centessa Pharmaceuticals-adr share price of $21.12 per share as on September 17, 2025 at 12:36 am IST.

What is the minimum amount required to buy Centessa Pharmaceuticals-adr Stock (CNTA) from India?

Indian investors can start investing in Centessa Pharmaceuticals-adr (CNTA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 12:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Centessa Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 12:36 am IST). Based on Centessa Pharmaceuticals-adr share’s latest price of $21.12 as on September 17, 2025 at 12:36 am IST, you will get 0.4735 shares of Centessa Pharmaceuticals-adr. Learn more about fractional shares .